Labs Say They’re Automated. The Workflow Tells a Different Story
Many labs consider themselves automated, but manual steps persist. Here’s where automation is working, where it’s falling short, and how some labs are starting to close the gaps.
Many labs consider themselves automated, but manual steps persist. Here’s where automation is working, where it’s falling short, and how some labs are starting to close the gaps.
Amplified Sciences has received CAP accreditation for its clinical laboratory, enabling broader commercial deployment of its PanCystPro assay for pancreatic cancer risk assessment, the company announced.
As autoimmune and allergy test volumes rise, labs are prioritizing workflow standardization and structured testing pathways to ensure reliable results, according to Santhosh Nair, president of immunodiagnostics at Thermo Fisher Scientific.
The accreditation covers liver health diagnostics, including Hepatotrack, a molecular diagnostic liquid biopsy that is predictive of acute liver rejection post-liver transplant.
The recommendations focus on using next-generation sequencing to evaluate off-target editing risks and chromosomal integrity.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
TCM Biotech has received FDA Breakthrough Device Designation for CatCHimera, a liquid biopsy platform for monitoring minimal residual disease in hepatocellular carcinoma using HBV–host genome integration biomarkers.
This clinical lab conference spotlight looks at why ADLM 2026 belongs on the radar for CLP readers. From the scientific program to the Clinical Lab Expo, the event offers practical ideas, fresh technology, and real conversations for people working across diagnostics and laboratory medicine. For lab professionals who want useful insight, sharper perspective, and stronger industry connections, this is a smart place to be.